Global Hereditary Cancer Testing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • Category : Healthcare & Pharma
  • |
  • ID : 681560
  • |
  • Publishe Date : 12-Nov-18
  • |
  • No of Pages: 119
  • |
  • Publisher : Global Info Research

Hereditary cancer testing is a process of identifying an inherited gene mutation that increases the risk of cancer development. It mainly includes predictive genetic testing and clinical DNA sequencing, in predictive genetic testing, patient?s family history is analyzed for any inherited mutation from ancestry. In DNA sequencing, entire DNA or genome of an individual is analyzed. It is useful for testing many genetic mutations at a time.

Scope of the Report:
This report studies the Hereditary Cancer Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hereditary Cancer Testing market by product type and applications/end industries.
The global Hereditary Cancer Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hereditary Cancer Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
Myriad Genetics
Myogenes
Laboratory Corporation of America
Biocartis
Quest Diagnostics
Pathway Genomics
Invitae Corporation
Strand Life Sciences

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Biopsy
Imaging
Others

Market Segment by Applications, can be divided into
Hospital
Clinics
Diagnostic Centers

Table of Contents

1 Hereditary Cancer Testing Market Overview
1.1 Product Overview and Scope of Hereditary Cancer Testing
1.2 Classification of Hereditary Cancer Testing by Types
1.2.1 Global Hereditary Cancer Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Hereditary Cancer Testing Revenue Market Share by Types in 2017
1.2.3 Biopsy
1.2.4 Imaging
1.2.5 Others
1.3 Global Hereditary Cancer Testing Market by Application
1.3.1 Global Hereditary Cancer Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.4 Global Hereditary Cancer Testing Market by Regions
1.4.1 Global Hereditary Cancer Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Hereditary Cancer Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hereditary Cancer Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hereditary Cancer Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Hereditary Cancer Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hereditary Cancer Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Hereditary Cancer Testing (2013-2023)
2 Manufacturers Profiles
2.1 Myriad Genetics
2.1.1 Business Overview
2.1.2 Hereditary Cancer Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Myriad Genetics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Myogenes
2.2.1 Business Overview
2.2.2 Hereditary Cancer Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Myogenes Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Laboratory Corporation of America
2.3.1 Business Overview
2.3.2 Hereditary Cancer Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Laboratory Corporation of America Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Biocartis
2.4.1 Business Overview
2.4.2 Hereditary Cancer Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biocartis Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Quest Diagnostics
2.5.1 Business Overview
2.5.2 Hereditary Cancer Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Quest Diagnostics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pathway Genomics
2.6.1 Business Overview
2.6.2 Hereditary Cancer Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pathway Genomics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Invitae Corporation
2.7.1 Business Overview
2.7.2 Hereditary Cancer Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Invitae Corporation Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Strand Life Sciences
2.8.1 Business Overview
2.8.2 Hereditary Cancer Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Strand Life Sciences Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hereditary Cancer Testing Market Competition, by Players
3.1 Global Hereditary Cancer Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Hereditary Cancer Testing Players Market Share
3.2.2 Top 10 Hereditary Cancer Testing Players Market Share
3.3 Market Competition Trend
4 Global Hereditary Cancer Testing Market Size by Regions
4.1 Global Hereditary Cancer Testing Revenue and Market Share by Regions
4.2 North America Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
4.5 South America Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
5 North America Hereditary Cancer Testing Revenue by Countries
5.1 North America Hereditary Cancer Testing Revenue by Countries (2013-2018)
5.2 USA Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
6 Europe Hereditary Cancer Testing Revenue by Countries
6.1 Europe Hereditary Cancer Testing Revenue by Countries (2013-2018)
6.2 Germany Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
6.3 UK Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
6.4 France Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Hereditary Cancer Testing Revenue by Countries
7.1 Asia-Pacific Hereditary Cancer Testing Revenue by Countries (2013-2018)
7.2 China Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
7.5 India Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
8 South America Hereditary Cancer Testing Revenue by Countries
8.1 South America Hereditary Cancer Testing Revenue by Countries (2013-2018)
8.2 Brazil Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Hereditary Cancer Testing by Countries
9.1 Middle East and Africa Hereditary Cancer Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
10 Global Hereditary Cancer Testing Market Segment by Type
10.1 Global Hereditary Cancer Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Hereditary Cancer Testing Market Forecast by Type (2018-2023)
10.3 Biopsy Revenue Growth Rate (2013-2023)
10.4 Imaging Revenue Growth Rate (2013-2023)
10.5 Others Revenue Growth Rate (2013-2023)
11 Global Hereditary Cancer Testing Market Segment by Application
11.1 Global Hereditary Cancer Testing Revenue Market Share by Application (2013-2018)
11.2 Hereditary Cancer Testing Market Forecast by Application (2018-2023)
11.3 Hospital Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
12 Global Hereditary Cancer Testing Market Size Forecast (2018-2023)
12.1 Global Hereditary Cancer Testing Market Size Forecast (2018-2023)
12.2 Global Hereditary Cancer Testing Market Forecast by Regions (2018-2023)
12.3 North America Hereditary Cancer Testing Revenue Market Forecast (2018-2023)
12.4 Europe Hereditary Cancer Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Hereditary Cancer Testing Revenue Market Forecast (2018-2023)
12.6 South America Hereditary Cancer Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Hereditary Cancer Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Hereditary Cancer Testing Picture
Table Product Specifications of Hereditary Cancer Testing
Table Global Hereditary Cancer Testing and Revenue (Million USD) Market Split by Product Type
Figure Global Hereditary Cancer Testing Revenue Market Share by Types in 2017
Figure Biopsy Picture
Figure Imaging Picture
Figure Others Picture
Table Global Hereditary Cancer Testing Revenue (Million USD) by Application (2013-2023)
Figure Hereditary Cancer Testing Revenue Market Share by Applications in 2017
Figure Hospital Picture
Figure Clinics Picture
Figure Diagnostic Centers Picture
Table Global Market Hereditary Cancer Testing Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (2013-2023)
Table Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table Myriad Genetics Hereditary Cancer Testing Type and Applications
Table Myriad Genetics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Myogenes Basic Information, Manufacturing Base and Competitors
Table Myogenes Hereditary Cancer Testing Type and Applications
Table Myogenes Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Laboratory Corporation of America Basic Information, Manufacturing Base and Competitors
Table Laboratory Corporation of America Hereditary Cancer Testing Type and Applications
Table Laboratory Corporation of America Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Biocartis Basic Information, Manufacturing Base and Competitors
Table Biocartis Hereditary Cancer Testing Type and Applications
Table Biocartis Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table Quest Diagnostics Hereditary Cancer Testing Type and Applications
Table Quest Diagnostics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Pathway Genomics Basic Information, Manufacturing Base and Competitors
Table Pathway Genomics Hereditary Cancer Testing Type and Applications
Table Pathway Genomics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Invitae Corporation Basic Information, Manufacturing Base and Competitors
Table Invitae Corporation Hereditary Cancer Testing Type and Applications
Table Invitae Corporation Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Strand Life Sciences Basic Information, Manufacturing Base and Competitors
Table Strand Life Sciences Hereditary Cancer Testing Type and Applications
Table Strand Life Sciences Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Global Hereditary Cancer Testing Revenue (Million USD) by Players (2013-2018)
Table Global Hereditary Cancer Testing Revenue Share by Players (2013-2018)
Figure Global Hereditary Cancer Testing Revenue Share by Players in 2016
Figure Global Hereditary Cancer Testing Revenue Share by Players in 2017
Figure Global Top 5 Players Hereditary Cancer Testing Revenue Market Share in 2017
Figure Global Top 10 Players Hereditary Cancer Testing Revenue Market Share in 2017
Figure Global Hereditary Cancer Testing Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Hereditary Cancer Testing Revenue (Million USD) by Regions (2013-2018)
Table Global Hereditary Cancer Testing Revenue Market Share by Regions (2013-2018)
Figure Global Hereditary Cancer Testing Revenue Market Share by Regions (2013-2018)
Figure Global Hereditary Cancer Testing Revenue Market Share by Regions in 2017
Figure North America Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure Europe Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure South America Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Table North America Hereditary Cancer Testing Revenue by Countries (2013-2018)
Table North America Hereditary Cancer Testing Revenue Market Share by Countries (2013-2018)
Figure North America Hereditary Cancer Testing Revenue Market Share by Countries (2013-2018)
Figure North America Hereditary Cancer Testing Revenue Market Share by Countries in 2017
Figure USA Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure Canada Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure Mexico Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Table Europe Hereditary Cancer Testing Revenue (Million USD) by Countries (2013-2018)
Figure Europe Hereditary Cancer Testing Revenue Market Share by Countries (2013-2018)
Figure Europe Hereditary Cancer Testing Revenue Market Share by Countries in 2017
Figure Germany Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure UK Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure France Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure Russia Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure Italy Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Hereditary Cancer Testing Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Hereditary Cancer Testing Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Hereditary Cancer Testing Revenue Market Share by Countries in 2017
Figure China Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure Japan Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure Korea Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure India Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Table South America Hereditary Cancer Testing Revenue by Countries (2013-2018)
Table South America Hereditary Cancer Testing Revenue Market Share by Countries (2013-2018)
Figure South America Hereditary Cancer Testing Revenue Market Share by Countries (2013-2018)
Figure South America Hereditary Cancer Testing Revenue Market Share by Countries in 2017
Figure Brazil Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure Argentina Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure Colombia Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Hereditary Cancer Testing Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Hereditary Cancer Testing Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hereditary Cancer Testing Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hereditary Cancer Testing Revenue Market Share by Countries in 2017
Figure Saudi Arabia Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure UAE Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure Egypt Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure Nigeria Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Figure South Africa Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
Table Global Hereditary Cancer Testing Revenue (Million USD) by Type (2013-2018)
Table Global Hereditary Cancer Testing Revenue Share by Type (2013-2018)
Figure Global Hereditary Cancer Testing Revenue Share by Type (2013-2018)
Figure Global Hereditary Cancer Testing Revenue Share by Type in 2017
Table Global Hereditary Cancer Testing Revenue Forecast by Type (2018-2023)
Figure Global Hereditary Cancer Testing Market Share Forecast by Type (2018-2023)
Figure Global Biopsy Revenue Growth Rate (2013-2018)
Figure Global Imaging Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Hereditary Cancer Testing Revenue by Application (2013-2018)
Table Global Hereditary Cancer Testing Revenue Share by Application (2013-2018)
Figure Global Hereditary Cancer Testing Revenue Share by Application (2013-2018)
Figure Global Hereditary Cancer Testing Revenue Share by Application in 2017
Table Global Hereditary Cancer Testing Revenue Forecast by Application (2018-2023)
Figure Global Hereditary Cancer Testing Market Share Forecast by Application (2018-2023)
Figure Global Hospital Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Diagnostic Centers Revenue Growth Rate (2013-2018)
Figure Global Hereditary Cancer Testing Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Hereditary Cancer Testing Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Hereditary Cancer Testing Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Hereditary Cancer Testing Revenue Market Forecast (2018-2023)
Figure Europe Hereditary Cancer Testing Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Hereditary Cancer Testing Revenue Market Forecast (2018-2023)
Figure South America Hereditary Cancer Testing Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Hereditary Cancer Testing Revenue Market Forecast (2018-2023)

Choose License Type